松油烯-４-醇对粘虫幼虫的生物活性

测定了杀虫植物砂地柏Sabina vulgaris Ant.的精油中主杀虫成分-松油烯-4-醇（terpinen 4.01）对粘虫Mythimna separata Walker幼虫的生物活性。结果表明,松油烯- 4-醇对粘虫主要表现为熏蒸作用,对粘虫3龄幼虫24 h的熏蒸LC₅₀为5.3473 μL/L ;还具一定触杀作用,对粘虫4龄幼虫24 h的LD₅₀为147.8 μg/虫。试虫的中毒症状可明显地分为兴奋、痉挛、麻痹和死亡4个阶段,而麻痹的部分试虫有复苏现象。可明显抑制Na⁺ ,K⁺ATP酶的活性,在兴奋期、痉挛期、麻痹期和复苏期,抑制率介于21.28%～34.92% 之间。离体条件下对Na⁺,K⁺ATP酶的I₅₀为133.75 μg·mL^-1;对AChE活性有一定的影响;对酯酶,在兴奋期,酶活力为对照的7.0%,在麻痹期则为对照的1.33倍,而复苏期试虫的酯酶活力与对照相当。     

三峡库区的渔业资源及保护

分析了三峡库区的水域特点,比较了1997-2004年鱼类的捕捞情况,说明三峡库区有着丰富的渔业资源。介绍了三峡库区的主要珍稀特产鱼类。三峡工程的修建,生态环境的破坏,对库区渔业资源造成了严重的威胁。加强对渔业资源的保护和科学合理的开发利用势在必行,有利于保护鱼类多样性,促进渔业资源的发展,维持库区生态平衡。     

尾羽龙(Caudipteryx)的新材料及其重要骨骼特征的补充和修订

尾羽龙和原始祖鸟一起被认为是最早发现的带有真正鸟类羽毛的恐龙（Ji et al., 1998）,迄今已发现的尾羽龙包括邹氏尾羽龙（Caudipteryx zoui）和董氏尾羽龙（Caudipteryx dongi）两种（周忠和、汪筱林,2000）,前者包括保存在中国地质博物馆的NGMC 97*4朅和NGMC 97*9朅两件标本,而后者依据的材料仅为保存在中国科学院古脊椎动物与古人类研究所的V 12344。以上标本都不是十分完整。本文依据最近新发现的两件几乎完整的尾羽龙标本,对该属的一些重要形态特征进行补充和修订,以期对其系统关系的讨论及其他相关理论问题的研究提供新的…     

Design,synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors

Neuraminidase (NA) is one of the particular potential targets for novel antiviral therapy. In this work, a series of neuraminidase inhibitors with the cyclohexene scaffold were studied based upon the combination of 3D-QSAR, molecular docking, and molecular dynamics techniques. The results indicate that the built 3D-QSAR models yield reliable statistical information: the correlation coefficient (r²) and cross-validation coefficient (q²) of CoMFA (comparative molecular field analysis) are 0.992 and 0.819; the r² and q² of CoMSIA (comparative molecular similarity analysis) are 0.992 and 0.863, respectively. Molecular docking and MD simulations were conducted to confirm the detailed binding mode of enzyme-inhibitor system. The new NA inhibitors had been designed, synthesized, and their inhibitory activities against group-1 neuraminidase were determined. One agent displayed excellent neuraminidase inhibition, with IC₅₀ value of 39.6?μM against NA, while IC₅₀ value for oseltamivir is 61.1?μM. This compound may be further investigated for the treatment of infection by the new type influenza virus.